Diagnostic utility of two case definitions for anaphylaxis: A comparison using a retrospective case notes analysis in the UK

Drug Safety

Volumn 33, Issue 1, 2010, Pages 57-64

  Erlewyn Lajeunesse, Michel ^a   Dymond, Sandra ^b   Slade, Ingrid ^c   Mansfield, Helen L ^d   Fish, Rosie ^d   Jones, Owen ^d   Benger, Jonathan R ^d,e  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^d UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

^e UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CHLORPHENIRAMINE; CORTICOSTEROID; SALBUTAMOL;

ADOLESCENT; ADULT; AGED; ALLERGIC REACTION; ANAPHYLAXIS; ARTICLE; ASTHMA; BRIGHTON COLLABORATION CASE DEFINITION; CHILD; COMPARATIVE STUDY; COMPUTER PROGRAM; CONFIDENCE INTERVAL; CONTROLLED STUDY; EMERGENCY WARD; FEMALE; GOLD STANDARD; HOSPITAL ADMISSION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SECOND SYMPOSIUM CASE DEFINITION; SENSITIVITY AND SPECIFICITY; URTICARIA;

ADOLESCENT; ADULT; ANAPHYLAXIS; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; EMERGENCY SERVICE, HOSPITAL; FEMALE; GREAT BRITAIN; HUMANS; INFANT; MALE; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 72049096867     PISSN: 01145916     EISSN: 11791942     Source Type: Journal    
DOI: 10.2165/11318970-000000000-00000     Document Type: Article

References (14)

1. Johansson SG, Hourihane JO, Bousquet J, et al. A revised nomenclature for allergy: an EAACI position statement from the EAACI Nomenclature Task Force. Allergy 2001; 56 (9): 813-824
2. Simons FE. Anaphylaxis. J Allergy Clin Immunol 2008; 121 (2 Suppl.): S402-7
3. Sampson HA, Munoz-Furlong A, Campbell RL, et al. Second Symposium on the Definition and Management of Anaphylaxis: summary report. Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network Symposium. J Allergy Clin Immunol 2006; 117 (2): 391-397
4. Ruggeberg JU, Gold MS, Bayas JM, et al. Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine 2007; 25 (31): 5675-5684
5. Erlewyn-Lajeunesse M, Bonhoeffer J, Ruggeberg JU, et al. Anaphylaxis as an adverse event following immunisation. J Clin Pathol 2007; 60 (7): 737-739
6. Advanced Life Support Group. Paediatric advanced life support: provider manual. Manchester: Advanced Life Support Group, 2007
7. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33 (1): 159-174
8. Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 1998; 17 (8): 857-872
9. Brown SG. Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol 2004; 114 (2): 371-6
10. Simons FE, Frew AJ, Ansotegui IJ, et al. Risk assessment in anaphylaxis: current and future approaches. J Allergy Clin Immunol 2007; 120 (1 Suppl.): S2-24
11. West SL, D'Aloisio AA, Ringel-Kulka T, et al. Population-based drug-related anaphylaxis in children and adolescents captured by South Carolina Emergency Room Hospital Discharge Database (SCERHDD) [2000-2002]. Pharmaco-epidemiol Drug Saf 2007; 16 (12): 1255-1267
12. Ross MP, Ferguson M, Street D, et al. Analysis of food-allergic and anaphylactic events in the National Electronic Injury Surveillance System. J Allergy Clin Immunol 2008; 121 (1): 166-171
13. Gaeta TJ, Clark S, Pelletier AJ, et al. National study of US emergency department visits for acute allergic reactions, 1993 to 2004. Ann Allergy Asthma Immunol 2007; 98 (4): 360-365
14. Lieberman P. Anaphylactic reactions during surgical and medical procedures. J Allergy Clin Immunol 2002; 110 (2 Suppl.): S64-9